ADAM23 and embryonal carcinoma: Downregulation of ADAM23 drives embryonic carcinoma P19 cells to differentiate into neuroectodermal cells [19], where ADAM23 suppresses neuronal differentiation via its disintegrin domain by inhibiting P27KIP1 function [32].